Under construction – not a live service
Sign in
Taking people in TürkiyeNo phase

Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia

Key facts

Who runs it
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Where
Istanbul, TürkiyeSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
10 Jan 2023
Planned end
1 Oct 2025
Type of study
Observational
Treatments tested
  • Central Sensitization Inventory
  • The Montreal Cognitive Assessment
  • Cognitive Symptom Severity Scale-Extended
  • Fibromyalgia Impact Questionnaire
  • Numeric rating scale
  • Hospital Anxiety and Depression Scale
Record updated
12 September 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Being diagnosed with fibromyalgia according to American College of Rheumatology 2016 criteria
  • Being between 18-65 years old
  • Being literate
  • Accepting to participate in the study

Who cannot take part

  • Concomitant systemic inflammatory disease, central nervous system disease (cortical involvement), active infection and malignancy history
  • History of illness that may lead to cognitive impairment
  • Being <18 and >65 years old
  • Being illiterate
  • Not accepting to participate in the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in Türkiye

  • Health Sciences UniversityIstanbul, TürkiyeContact: Feyza Yücel, M.D.Taking people

About the trial

What the trial wants to find out

The aim of the study is to investigate the relationship between central sensitization parameters and cognitive dysfunction in patients with fibromyalgia.The main questions it aims to answer are:

Read full original descriptionShow less

Do central sensitization symptoms affect cognitive dysfunction in patients with fibromyalgia? To what extent do central sensitization symptoms affect objective and subjective cognitive complaints in fibromyalgia patients? How do cognitive complaints relate to other clinical parameters, including disease severity, in these patients?

The group in the trial

  • Patients

    Patients with fibromyalgia

    Treatment: Central Sensitization Inventory, The Montreal Cognitive Assessment, Cognitive Symptom Severity Scale-Extended, Fibromyalgia Impact Questionnaire, Numeric rating scale, and Hospital Anxiety and Depression Scale

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Investigation of the Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Patients With Fibromyalgia
Fit questions
Built from NCT06948903, who can take part
Record updated
12 September 2025